Inte, Mary Joy T.
HRN: 13-87-32 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/28/2022
CEFUROXIME 1.5GM (VIAL)
12/28/2022
01/04/2023
IV
1.5 Gm
Q8h
PCAP C T/C CHD
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes